Fredrik Strömholm
Direttore/Membro del Consiglio presso Ferrosan Medical Devices A/S
Profilo
Fredrik Strömholm has worked as a Director at Ferrosan Medical Devices A since 2011.
Posizioni attive di Fredrik Strömholm
Società | Posizione | Inizio |
---|---|---|
Ferrosan Medical Devices A/S
Ferrosan Medical Devices A/S Medical SpecialtiesHealth Technology Ferrosan Medical Devices A/S manufactures and distributes consumer health and pharmaceutical products and devices. It produces gelatin-based topical absorbable haemostatic products. The firm's products are surgiflo, which is a a sterile, absorbable porcine gelatin paste intended for haemostatic use by applying to a bleeding surface; surgifoam, which is a sterile, water-insoluble, malleable, porcine gelatin absorbable sponge intended for haemostatic use by applying to a bleeding surface; and spongostan, which is a sterile, water-insoluble, malleable, porcine gelatin absorbable sponge intended for haemostatic use by applying to a bleeding surface. The company was founded in May 2010 and is headquartered in Søborg, Denmark. | Direttore/Membro del Consiglio | 01/01/2011 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Ferrosan Medical Devices A/S
Ferrosan Medical Devices A/S Medical SpecialtiesHealth Technology Ferrosan Medical Devices A/S manufactures and distributes consumer health and pharmaceutical products and devices. It produces gelatin-based topical absorbable haemostatic products. The firm's products are surgiflo, which is a a sterile, absorbable porcine gelatin paste intended for haemostatic use by applying to a bleeding surface; surgifoam, which is a sterile, water-insoluble, malleable, porcine gelatin absorbable sponge intended for haemostatic use by applying to a bleeding surface; and spongostan, which is a sterile, water-insoluble, malleable, porcine gelatin absorbable sponge intended for haemostatic use by applying to a bleeding surface. The company was founded in May 2010 and is headquartered in Søborg, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Fredrik Strömholm